Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. Dec 2001; 85(12): 1813–1823.
PMCID: PMC2364002
Activation and activities of the p53 tumour suppressor protein
É Bálint1 and K H Vousden1
1NCI at Frederick, Building 560, Room 22–96, 1050 Boyles Street, Frederick, MD, 21702-1201, USA
The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy. © 2001 Cancer Research Campaign
Full Text
The Full Text of this article is available as a PDF (166K).
Articles from British Journal of Cancer are provided here courtesy of
Cancer Research UK